Class Actions
AlloVir, Inc.
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
January 22, 2024
Investigations
Search
Categories
Archives
Investment Monitoring From Robbins LLP
To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.
Class Actions
BioVie Inc.
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
January 22, 2024
Class Actions
TaskUs, Inc.
TaskUs, Inc. Shareholders Partially Beat Defendants’ Motion to Dismiss the Class Action Complaint
January 17, 2024
Class Actions
Future FinTech Group Inc.
Future FinTech Group Inc.’s (FTFT) CEO Charged With Fraud For Manipulating The Price Of The Company’s Stock
January 17, 2024
Class Actions
Mobileye Global Inc.
Mobileye Global Inc. Misled Investors Regarding Supply Chain Restraints
January 17, 2024
Class Actions
January 16, 2024
Class Actions
BioNTech SE
BioNTech SE (BNTX) Allegedly Misled Investors Regarding its Business Prospects
January 16, 2024
Class Actions
Assertio Holdings, Inc.
Assertio Holdings, Inc. (ASRT) Allegedly Misled Investors Regarding its Reliance on Indocin and Integration of Spectrum Pharmaceuticals, Inc.
January 8, 2024
Class Actions
Maison Solutions Inc.
Maison Solutions Inc. (MSS) Misled Investors Regarding its Related Entities
January 8, 2024
Protect your